Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections

Euro Surveill. 2012 Dec 6;17(49):20334. doi: 10.2807/ese.17.49.20334-en.

Abstract

We present a rigorously validated and highly sensitive confirmatory real-time RT-PCR assay (1A assay) that can be used in combination with the previously reported upE assay. Two additional RT-PCR assays for sequencing are described, targeting the RdRp gene (RdRpSeq assay) and N gene (NSeq assay), where an insertion/deletion polymorphism might exist among different hCoV-EMC strains. Finally, a simplified and biologically safe protocol for detection of antibody response by immunofluorescence microscopy was developed using convalescent patient serum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coronavirus / classification
  • Coronavirus / genetics
  • Coronavirus / isolation & purification*
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / virology
  • Fluorescent Antibody Technique
  • Germany
  • Humans
  • Laboratories / standards
  • Polymorphism, Restriction Fragment Length
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • Reverse Transcriptase Polymerase Chain Reaction / methods*
  • Sensitivity and Specificity
  • Sequence Analysis, DNA
  • Virology / methods

Substances

  • RNA, Viral